Sorry, you need to enable JavaScript to visit this website.

Centre for Bio Separation Technology (CBST)

The research and development activities will be focused on the following interconnected themes:

  • Separation Science
  • Immunotechnology
  • Bioactive molecules from plant extracts
  • Recombinant protein expressions
  • DEPARTMENT OF SCIENCE & TECHNOLOGY (DST), Govt. of India, Under the High Priority Area of Research.
  • DEPARTMENT OF BIOTECHNOLOGY programme support on improved production and processing of therapeutic proteins.
  • UNIVERSITY OF TECHNOLOGY COMPIEGNE (UTC), France, under the collaborative agreement.
  • DEPARTMENT OF SCIENCE & TECHNOLOGY: Engineering of beta-glucosidases for improved yield of glycoconjugates (collaboration with IIT Delhi).
  • PALL, European Operations: Study and evaluation of new chromatographic supports.
  • TIFAC, Govt. of India, New Delhi. Development of novel process in isolating standardized extract of Aloe vera and its application for diabetes control. Bioprocess and Bioproducts Programme.
  • CEFIPRA/IFCPAR: The immuno-psychiatry in South India Study (lPS): Immunogenetic and immunophenotype characterization of Major Psychoses.
  • DST-SERB (Young Scientists): Immobilized metal-ion affinity (IMA) microfluidic system for probing proteins at molecular and cellular levels.
  • DST-SERB (Young Scientists): Evaluation of applicability of arginine-modifying tags for middle-down proteomics by electrospray mass spectrometry.
  • DST-SERB (Young Scientists): Structural studies of plant pathogenesis related proteins.
  • BIRAC-CEFIPRA programme (DBT): Oxidized HDL ApoA1 as a risk predictor of CVDs and development of novel diagnostics
  • KAUST (King Abdullah University of Science and Technology, Saudi Arabia) Synthesis of poly(ethylene oxide dendrimers) and chemical modification with current cancer drugs; in vivo validation
  • DST-SERB: Identification of the latent tuberculosis specific marker by the immunoproteomic analysis of the cell wall and membrane proteins of M. tuberculosis (collaboration with National Institute of Research in Tuberculosis, Chennai)
  • CEFIPRA/IFCPAR, New Delhi: Cost Effective Strategy for the induction of immune tolearnce to therapeutic factor VIII in haemophilia. (in collaboration with INSERM UMRS 1138, Paris, France; VIRCHOW-Biotech Pvt.Ltd; SPAN Diagnostics SARL, Compiegne, France).
  • Biocon Limited, Bangalore
  • PALL Corporation, France
  • BIA Separations, Slovenia